Thymosin Alpha-1 / KPV / LL-37 – Advanced Immune & Inflammation Support Formula

Clinically Backed Support for Immune Modulation, Inflammation Control, and Pathogen Defense

Formulation: 10mg Thymosin Alpha-1 + 10mg KPV + 5mg LL-37 per multi-peptide vial (2mL total volume)
Classification: Prescription Required – Injection Use

This triple-action peptide blend is formulated for individuals seeking powerful immune system optimization, inflammation reduction, and antimicrobial defense. By combining:

• Thymosin Alpha-1 (Tα1): A proven immune modulator used in chronic infections and immune dysfunction.

• KPV (Lys-Pro-Val): A potent anti-inflammatory peptide fragment of alpha-MSH.

• LL-37: A natural antimicrobial peptide with wound healing and tissue regeneration benefits.

The result is a synergistic formula designed to improve recovery, resilience, and long-term wellness.

🔬 Mechanisms of Action & Research Applications

🧬 Thymosin Alpha-1 (Tα1)

• Enhances T-cell function and immune surveillance

• Balances cytokine signaling to reduce excessive inflammation

• Studied in chronic infections, immune suppression, and post-viral recovery

• Garaci et al., 2007 – Demonstrated improved immune activity in viral infection models

• King et al., 2015 – Showed reduced inflammatory markers and improved immune regulation

🧬 KPV (Lys-Pro-Val)

• Inhibits pro-inflammatory cytokines such as TNF-α and IL-6

• Supports wound healing and gut barrier repair

• Demonstrates systemic inflammation control in chronic conditions

• Catania et al., 2010 – Reported anti-inflammatory effects in colitis and skin inflammation models

• Lipton et al., 2018 – Found systemic reduction of inflammation and faster wound healing

🧬 LL-37

• Broad-spectrum antimicrobial activity against bacteria, viruses, and fungi

• Prevents immune overactivation while promoting balanced defense

• Enhances angiogenesis and accelerates wound closure

• Mookherjee et al., 2006 – Demonstrated antimicrobial and immune-modulating activity

• Dürr et al., 2006 – Found LL-37 promotes wound repair and vascular regeneration

💡 Key Clinical & Research Applications

• Chronic or recurrent infections

• Post-viral recovery & immune optimization

• Autoimmune and inflammatory conditions

• Gut barrier repair & leaky gut support

• Wound healing and regenerative recovery

• Immune support during periods of high stress or compromised states

💉 Suggested Dosing Guidelines

• Injection route: Subcutaneous

• Typical protocol: 10 units daily or every other day, per provider direction

• Duration: 4–12 weeks depending on clinical goals

• May be combined with other regenerative or immune peptides under clinical supervision

⚕️ Provider Oversight

This blend is prescribed and monitored through Arizona Sports Medicine, ensuring:

• U.S.-based compounding pharmacy sourcing

• Verified purity and sterility

• Direct provider support and clinical integration into recovery or immune optimization plans

📦 What’s Included With Every Order

• 1 multi-peptide vial (10mg Tα1 / 10mg KPV / 5mg LL-37)

• Bacteriostatic water for reconstitution

• Sterile syringes and alcohol pads

• Clinical dosing guide for home use

• Optional virtual provider consultation

📧 Email: Admin@ArizonaSportsMed.com
📞 Call/Text: 480-400-6225

🔬 Built for Immunity. Designed by Providers. Backed by Science.

This immune-enhancing, inflammation-controlling, and pathogen-defending blend offers a research-backed solution for those seeking to strengthen defenses, recover faster, and support long-term health—safely and effectively under medical guidance.